TNFA

TNF Pharmaceuticals, Inc. TNFA

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TNFA CHRO CRVO IMVIF APGN CYCC CSCI TVRD TSBX OMGA
6M -69.68 % -94.23 % -23.87 % 0.00 % -38.57 % -88.90 % 0.00 % -62.34 % -1.31 % -88.68 %
YTD -95.48 % -81.33 % 217.49 % 0.00 % -40.75 % -92.85 % -0.37 % 34.29 % -33.95 % -81.77 %
1Y -96.83 % -87.38 % -46.28 % 0.00 % -93.88 % -96.68 % -26.49 % 34.29 % -46.69 % -95.79 %
3Y -97.28 % -97.19 % -6.35 % -100.00 % -96.38 % -99.86 % -54.67 % 34.29 % -96.77 % -97.81 %
5Y -97.28 % -97.19 % -88.76 % -100.00 % -96.38 % -99.95 % -54.67 % 34.29 % -96.77 % -99.11 %
10Y -97.28 % -97.19 % -99.99 % -100.00 % -96.38 % -100.00 % -54.67 % 34.29 % -96.77 % -99.11 %
From the beginning -97.28 % -97.19 % -100.00 % -100.00 % -96.38 % -100.00 % -54.67 % 34.29 % -96.77 % -99.11 %

Dividend

Cyclacel Pharmaceuticals, Inc.